Neomed Management
51
27M
25
1.89
6
0.51
16
- Stages of investment
- Areas of investment
Summary
Neomed Management appeared to be the VC, which was created in 1997. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Neomed Management, startups are often financed by Andera Partners, Gimv, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Gimv, Legend Capital, BioMedPartners. In the next rounds fund is usually obtained by Andera Partners, OrbiMed, Gimv.
The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Sonendo, Creabilis, Wilson Therapeutics.
The overall number of key employees were 3.
The typical startup value when the investment from Neomed Management is 10-50 millions dollars. The top activity for fund was in 2014. The top amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. This Neomed Management works on 7 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 7 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 51
- Lead investments
- 6
- Exits
- 16
- Rounds per year
- 1.89
- Follow on index
- 0.51
- Investments by industry
- Health Care (42)
- Biotechnology (36)
- Medical (27)
- Medical Device (24)
- Manufacturing (7) Show 11 more
- Investments by region
-
- United States (16)
- Switzerland (18)
- Germany (6)
- United Kingdom (4)
- France (1) Show 5 more
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 41M
- Group Appearance index
- 0.98
- Avg. company exit year
- 9
- Avg. multiplicator
- 1.65
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Avitide | 06 Aug 2015 | Biotechnology, Health Care, Life Science | Late Stage Venture | 7M | United States, Lebanon, New Hampshire |
| Precision Ocular | 01 Mar 2021 | Health Care, Medical, Therapeutics | Early Stage Venture | 37M | Oxfordshire, Oxford, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.